{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:05:56Z","timestamp":1789373156571,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.msard.2026.107423","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:53:57Z","timestamp":1785858837000},"page":"107423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and serological features of systemic autoimmune overlap in AQP4-IgG positive neuromyelitis optica spectrum disorder: a Mexican cohort study"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-7314","authenticated-orcid":false,"given":"Yazmin","family":"Martinez-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-4561","authenticated-orcid":false,"given":"Alexis","family":"Garc\u00eda-Sarreon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique Isaac","family":"Tetlalmatzi-Azuara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithel Alejandro","family":"Valenzuela-Mendivil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jossy Noril\u00ed","family":"Vargas-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Pi\u00f1a-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Domingo Jos\u00e9","family":"Coutinho-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Flores-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-6307","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Rivas-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107423_bib0001","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.14973","article-title":"Neuromyelitis optica spectrum disorders (NMOSD) and systemic lupus erythematosus (SLE): dangerous duo","author":"Abou Raya","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.msard.2026.107423_bib0002","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","article-title":"Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"268","author":"Akaishi","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107423_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1620\/tjem.2023.J034","article-title":"Time-dependent analysis of sicca symptoms and anti-Ro\/SSA and anti-La\/SSB antibodies in patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder","volume":"260","author":"Akaishi","year":"2023","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.msard.2026.107423_bib0004","doi-asserted-by":"crossref","DOI":"10.2174\/1871524916666160229115047","article-title":"Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences","volume":"18","author":"Alonso","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.msard.2026.107423_bib0005","article-title":"Epidemiology of neuromyelitis optica in Latin America","author":"Alvarenga","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107423_bib0006","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","article-title":"EULAR\/ACR classification criteria for SLE","volume":"49","author":"Aringer","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.msard.2026.107423_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00896-6","article-title":"New criteria for lupus","author":"Aringer","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.msard.2026.107423_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-023-06611-4","article-title":"Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases","author":"Carnero Contentti","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107423_bib0009","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-021-01000-2","article-title":"Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an update for the rheumatologist","author":"Cruz","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.msard.2026.107423_bib0010","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2302035","article-title":"Systemic connective tissue disease and neuromyelitis optica spectrum disorder coexistence: a systematic review and meta-analysis","volume":"23","author":"Esposito","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.msard.2026.107423_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-014-3066-3","article-title":"Neuromyelitis optica spectrum disorders associated with other autoimmune diseases","author":"Freitas","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.msard.2026.107423_bib0012","article-title":"Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis","volume":"104","author":"Garc\u00edaSarre\u00f3n","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107423_bib0013","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-019-01176-6","article-title":"Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders","author":"Gkaniatsou","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2026.107423_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185104","article-title":"Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: results from a routine population survey","volume":"12","author":"Jardel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107423_bib0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1352458520933884","article-title":"Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD","volume":"27","author":"Kunchok","year":"2021","journal-title":"Multiple Scler. J."},{"key":"10.1016\/j.msard.2026.107423_bib0016","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203319877255","article-title":"Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience","volume":"28","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2026.107423_bib0017","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/neu.2016.49","article-title":"Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica","volume":"29","author":"Pereira","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.msard.2026.107423_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106604","article-title":"LATAM-Panorama-NMOSD: epidemiological, clinical, and paraclinical features of Neuromyelitis Optica spectrum disorder in latin America and the Caribbean, a systematic review and meta-analysis","author":"Petersen","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107423_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non\u2013organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.msard.2026.107423_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103083","article-title":"Status of the neuromyelitis optica spectrum disorder in Latin America","volume":"53","author":"Rivera","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107423_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69224-3","article-title":"Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population","volume":"10","author":"Romero-Hidalgo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107423_bib0022","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/acn3.52310","article-title":"Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay","volume":"12","author":"Said","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107423_bib0023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10067-023-06809-z","article-title":"Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren\u2019s syndrome","volume":"43","author":"Sami","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.msard.2026.107423_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","author":"Shahmohammadi","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107423_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-023-01112-y","article-title":"Neuromyelitis optica: pathogenesis overlap with other autoimmune diseases","author":"Taheri","year":"2023","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.msard.2026.107423_bib0026","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13425-1","article-title":"Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study","volume":"272","author":"Tun\u00e7","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107423_bib0027","article-title":"The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107423_bib0028","doi-asserted-by":"crossref","unstructured":"Wingerchuk, D.M., Banwell, B., Bennett, J.L., Cabre, P., Carroll, W., Chitnis, T., De Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J.H., Tenembaum, S., Traboulsee, A.L., Waters, P., Wellik, K.E., Weinshenker, B.G., 2015. VIEWS & REVIEWS International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"10.1016\/j.msard.2026.107423_bib0029","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"New England J. Med."},{"key":"10.1016\/j.msard.2026.107423_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","author":"Wingerchuk","year":"2012","journal-title":"Multiple Scler. J."},{"key":"10.1016\/j.msard.2026.107423_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-025-03538-3","article-title":"Concomitant Sj\u00f6gren\u2019s disease in patients with NMOSD: impacts on neurologic disease severity and recurrence","volume":"27","author":"Wu","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.msard.2026.107423_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-018-1182-5","article-title":"Neuromyelitis optica spectrum disorders with and without connective tissue disorders","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Neurol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600458X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600458X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:04:22Z","timestamp":1789369462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600458X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S221103482600458X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107423","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and serological features of systemic autoimmune overlap in AQP4-IgG positive neuromyelitis optica spectrum disorder: a Mexican cohort study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107423"}}